GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and ...

ProPhase Labs (NASDAQ:PRPH – Get Free Report) is expected to be releasing its earnings data before the market opens on ...

This quarter's event is focused on MicroCap companies who are undervalued and have a catalyst. ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer ...

ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations ...

Shares of ProPhase Labs, Inc. (PRPH) have been struggling lately and have lost 21% over the past week. However, a hammer ...

ProPhase Labs (PRPH) is focused on immediate cash generation through two key initiatives: strategic alternatives including a potential sale of its genomics assets and the aggressive collection of ...

This quarter’s event is focused on MicroCap companies who are undervalued and have a catalyst. ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer ...